Antisignal recognition particle-positive polymyositis successfully treated with myeloablative autologous stem cell transplantation

Annals of the Rheumatic Diseases

Volumn 68, Issue 3, 2009, Pages 447-448

  Henes, J C ^a   Heinzelmann, F ^a   Wacker, A ^a   Seelig, H P ^b   Klein, R ^a   Bornemann, A ^a   Faul, C ^a   Kanz, L ^a   Koetter, I ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Private Laboratories Seelig   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROTEIN ANTIBODY; SIGNAL RECOGNITION PARTICLE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CASE REPORT; CLINICAL ASSESSMENT; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYELOABLATIVE CONDITIONING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POLYMYOSITIS; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ADULT; AUTOANTIBODIES; FEASIBILITY STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; POLYMYOSITIS; SIGNAL RECOGNITION PARTICLE; TRANSPLANTATION CONDITIONING;

EID: 61449163969     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.094755     Document Type: Letter

References (3)

1. Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Venkovsky J, et al. Anti-SRP autoantibodies, marker for a necrotizing myopathy. Ann Rheum Dis 2006;65:1635-8.
2. Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, et al. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 1998;92:3505-14.
3. Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002;46:2301-9.